These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 9917523)
1. Prognostic significance of the MIB-1 labeling index for patient with craniopharyngioma. Nishi T; Kuratsu J; Takeshima H; Saito Y; Kochi M; Ushio Y Int J Mol Med; 1999 Feb; 3(2):157-61. PubMed ID: 9917523 [TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical detection of female sex hormone receptors in craniopharyngiomas: correlation with clinical and histologic features. Izumoto S; Suzuki T; Kinoshita M; Hashiba T; Kagawa N; Wada K; Fujimoto Y; Hashimoto N; Saitoh Y; Maruno M; Yoshimine T Surg Neurol; 2005 Jun; 63(6):520-5; discussion 525. PubMed ID: 15936368 [TBL] [Abstract][Full Text] [Related]
3. [Craniopharyngioma with rapid regrowth--role of MIB-1 labeling index]. Anegawa S; Hayashi T; Nakagawa S; Furukawa Y; Tomokiyo M No Shinkei Geka; 2001 Aug; 29(8):727-33. PubMed ID: 11554090 [TBL] [Abstract][Full Text] [Related]
6. The significance of Ki-67/MIB-1 labeling index in human meningiomas: a literature study. Abry E; Thomassen IØ; Salvesen ØO; Torp SH Pathol Res Pract; 2010 Dec; 206(12):810-5. PubMed ID: 20951502 [TBL] [Abstract][Full Text] [Related]
7. Proliferative activity in craniopharyngiomas: clinicopathological correlations in adults and children. Raghavan R; Dickey WT; Margraf LR; White CL; Coimbra C; Hynan LS; Rushing EJ Surg Neurol; 2000 Sep; 54(3):241-7; discussion 248. PubMed ID: 11118571 [TBL] [Abstract][Full Text] [Related]
8. Postoperative residual tumor growth of meningioma can be predicted by MIB-1 immunohistochemistry. Nakaguchi H; Fujimaki T; Matsuno A; Matsuura R; Asai A; Suzuki I; Sasaki T; Kirino T Cancer; 1999 May; 85(10):2249-54. PubMed ID: 10326705 [TBL] [Abstract][Full Text] [Related]
9. Assessment of proliferation index with MIB-1 as a prognostic factor in radiation therapy for cervical cancer. Suzuki M; Tsukagoshi S; Saga Y; Ohwada M; Sato I Gynecol Oncol; 2000 Nov; 79(2):300-4. PubMed ID: 11063661 [TBL] [Abstract][Full Text] [Related]
10. Proliferation index determined by MIB-1 and recurrence in endometrial cancer. Geisler JP; Wiemann MC; Zhou Z; Miller GA; Geisler HE Gynecol Oncol; 1996 Jun; 61(3):373-7. PubMed ID: 8641618 [TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic study of forty-four histologically pure supratentorial oligodendrogliomas. Prayson RA; Mohan DS; Song P; Suh JH Ann Diagn Pathol; 2000 Aug; 4(4):218-27. PubMed ID: 10982299 [TBL] [Abstract][Full Text] [Related]
12. Study of the MIB-1 labeling index as a predictor of tumor progression in pilocytic astrocytomas in children and adolescents. Bowers DC; Gargan L; Kapur P; Reisch JS; Mulne AF; Shapiro KN; Elterman RD; Winick NJ; Margraf LR J Clin Oncol; 2003 Aug; 21(15):2968-73. PubMed ID: 12885817 [TBL] [Abstract][Full Text] [Related]
13. Analysis of immunohistochemical expression of p53 and the proliferation marker Ki-67 antigen in skull base chordomas: relationships between their expression and prognosis. Sakai K; Hongo K; Tanaka Y; Nakayama J Brain Tumor Pathol; 2007; 24(2):57-62. PubMed ID: 18095132 [TBL] [Abstract][Full Text] [Related]
14. Clinico-pathological and immunohistochemical characteristics associated to recurrence/regrowth of craniopharyngiomas. Tena-Suck ML; Salinas-Lara C; Arce-Arellano RI; Rembao-Bojórquez D; Morales-Espinosa D; Sotelo J; Arrieta O Clin Neurol Neurosurg; 2006 Oct; 108(7):661-9. PubMed ID: 16500745 [TBL] [Abstract][Full Text] [Related]
15. Prognostic value of cell cycle proteins p27(kip1) and MIB-1, and the cell adhesion protein CD44s in surgically treated patients with prostate cancer. Vis AN; Noordzij MA; Fitoz K; Wildhagen MF; Schröder FH; van der Kwast TH J Urol; 2000 Dec; 164(6):2156-61. PubMed ID: 11061947 [TBL] [Abstract][Full Text] [Related]
16. Implications of prognostic markers in brain tumors. Grzybicki DM; Moore SA Clin Lab Med; 1999 Dec; 19(4):833-47. PubMed ID: 10572718 [TBL] [Abstract][Full Text] [Related]
17. pT1 clear cell renal cell carcinoma: a study of the association between MIB-1 proliferative activity and pathologic features and cancer specific survival. Cheville JC; Zincke H; Lohse CM; Sebo TJ; Riehle D; Weaver AL; Blute ML Cancer; 2002 Apr; 94(8):2180-4. PubMed ID: 12001115 [TBL] [Abstract][Full Text] [Related]
18. MIB-1 labeling index as a prognostic indicator for survival in patients with FIGO stage IB squamous cell carcinoma of the cervix. Ho DM; Hsu CY; Chiang H Gynecol Oncol; 2000 Jan; 76(1):97-102. PubMed ID: 10620448 [TBL] [Abstract][Full Text] [Related]
19. Prognostic relevance of proliferative activity evaluated by Mib-1 immunostaining in node negative breast cancer. Neri A; Marrelli D; Pedrazzani C; Caruso S; De Stefano A; Mariani F; Megha T; De Marco G; Corso G; Pinto E; Roviello F Eur J Surg Oncol; 2008 Dec; 34(12):1299-303. PubMed ID: 18164172 [TBL] [Abstract][Full Text] [Related]
20. [Expression of proliferating cell nuclear antigen in craniopharyngioma and tumor recurrence]. Pan J; Qi ST; Deng YJ; Ding YQ; Peng L; Li XQ Di Yi Jun Yi Da Xue Xue Bao; 2002 Apr; 22(4):363-5. PubMed ID: 12390748 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]